135326-22-6 Gadoxetate Disodium
Nazwa produktu: |
Gadoxetate Disodium |
Angielska nazwa |
Gadoxetate Disodium;Gadoxetate Disodium [USAN]; gadolinium ethoxybenzyl DTPA; Bay 86-4873; Disodium (N-((2S)-2-(bis(carboxymethyl)amino)-3-(p-ethoxyphenyl)propyl)-N-(2-(bis(carboxymethyl)amino)ethyl)glycinato(5-))gadolinate(2-); Eovist; Eovist injection; Gadolinium EOB DTPA; Gadoxetic acid disodium; Gd-(S)-EOB-DTPA; Primovist; Primovist/Eovist; UNII-HOY74VZE0M; ZK 139834; Gadolinate(2-), (N-(2-(bis((carboxy-kappaO)methyl)amino-kappaN)-3-(4-ethoxyphenyl)propyl)-N-(2-(bis((carboxy-kappaO)methyl)amino-kappaN)ethyl)glycinato(5-)-kappaN,kappaO)-, disodium, (SA-8-11252634-(S))- |
MF |
C23H28GdN3O11・2Na |
Masie cząsteczkowej |
725.7142 |
Nr CAS |
135326-22-6 |
Struktury molekularnej |
|
Symbole zagrożenia |
|
Kody ryzyka |
|
Bezpieczeństwo opis |
|
|